133 related articles for article (PubMed ID: 2897304)
1. Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs.
McDevitt DG
Eur Heart J; 1987 Dec; 8 Suppl M():9-14. PubMed ID: 2897304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
Meier J
Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
6. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
7. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
8. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.
Ågesen FN; Weeke PE; Tfelt-Hansen P; Tfelt-Hansen J;
Pharmacol Res Perspect; 2019 Aug; 7(4):e00496. PubMed ID: 31338197
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.
Riddell JG; Harron DW; Shanks RG
Clin Pharmacokinet; 1987 May; 12(5):305-20. PubMed ID: 2886244
[TBL] [Abstract][Full Text] [Related]
11. [Beta blockers in migraine prophylaxis].
Shimizu T
Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of beta blockers and their role in clinical practice.
McDevitt DG
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S5-11. PubMed ID: 2439820
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
14. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M; Duchêne-Marullaz P; Moundanga JL
Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
[TBL] [Abstract][Full Text] [Related]
15. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.
Bouchard J; Shepherd G; Hoffman RS; Gosselin S; Roberts DM; Li Y; Nolin TD; Lavergne V; Ghannoum M;
Crit Care; 2021 Jun; 25(1):201. PubMed ID: 34112223
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol.
Egginger G; Lindner W; Vandenbosch C; Massart DL
Biomed Chromatogr; 1993; 7(6):277-95. PubMed ID: 7905307
[TBL] [Abstract][Full Text] [Related]
18. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
Feely J; Peden N
Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of beta-blockers.
Aqil M; Sultana Y; Ali A
Expert Opin Drug Deliv; 2006 May; 3(3):405-18. PubMed ID: 16640500
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor blockers and the blood-brian barrier.
Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
